Octagon Capital Advisors is a global investment firm specializing in public and private healthcare companies. With a focus on long-term investments, Octagon Capital partners with portfolio companies to drive innovation in the healthcare sector. They manage capital on behalf of various global institutions, including university endowments, non-profit foundations, family offices, pension funds, and established asset managers.

Their private portfolio includes a range of companies operating in different sectors of healthcare. These companies include 4D Molecular Therapeutics, a gene therapy company; Abogen Biosciences, a biotechnology company developing mRNA-based therapeutics; Affinia Therapeutics, an innovative gene therapy company; and Aktis Oncology, a biotechnology company focused on targeted radiopharmaceuticals for solid tumors. Octagon's commitment to supporting healthcare innovation and their extensive portfolio make them a trusted partner in the industry.

With a global perspective and a focus on long-term growth, Octagon Capital Advisors is at the forefront of investment in the healthcare sector